Invesco Health Care Fund Class R6 (GGHSX)

NASDAQ · Mutual Fund · Delayed Price · Currency is USD
38.80
-0.04 (-0.10%)
At close: Apr 2, 2026
Fund Assets1.23B
Expense Ratio0.72%
Min. Investment$1,000,000
Turnover59.00%
Dividend (ttm)2.20
Dividend Yield5.67%
Dividend Growth20.01%
Payout Frequencyn/a
Ex-Dividend DateDec 18, 2025
Previous Close38.84
YTD Return-5.39%
1-Year Return6.83%
5-Year Return18.23%
52-Week Low35.61
52-Week High45.36
Beta (5Y)n/a
Holdings78
Inception DateApr 4, 2017

About GGHSX

Invesco Health Care Fund Class R6 is a mutual fund focused on achieving long-term capital growth by investing primarily in equity securities of health care companies worldwide. The fund targets industry leaders and innovators across various segments within the health care sector, including health care equipment, biotechnology, pharmaceuticals, distributors, and managed care. As of the most recent data, the portfolio is heavily weighted toward U.S. companies, with additional exposure to select international markets such as the Netherlands, Switzerland, and the United Kingdom. The fund typically maintains a diversified basket of large-cap health care firms, emphasizing entities with strong management and a history of leadership in their subsectors. With an annual turnover rate around 56%, the fund actively manages its holdings to capitalize on emerging trends and shifts within the global health care industry. The Class R6 share class is structured for institutional investors and comes with a competitive expense ratio, supporting strategies that seek to balance risk with the potential for robust, long-term returns. In the broader financial market, the fund serves as a specialized vehicle for those seeking concentrated exposure to the evolving health care sector, a critical component of the global economy.

Fund Family Invesco
Category Health
Performance Rating Average
Risk Rating Average
Stock Exchange NASDAQ
Ticker Symbol GGHSX
Index S&P Composite 1500 Health Care TR

Performance

GGHSX had a total return of 6.83% in the past year, including dividends. Since the fund's inception, the average annual return has been 7.28%.

Top 10 Holdings

44.66% of assets
NameSymbolWeight
Eli Lilly and CompanyLLY9.55%
Boston Scientific CorporationBSX5.10%
AbbVie Inc.ABBV5.02%
Cencora, Inc.COR4.73%
Gilead Sciences, Inc.GILD3.89%
AstraZeneca PLCAZN3.80%
argenx SEARGX3.62%
Johnson & JohnsonJNJ3.41%
McKesson CorporationMCK3.21%
Thermo Fisher Scientific Inc.TMO2.33%
View More Holdings

Dividend History

Ex-DividendAmountPay Date
Dec 18, 2025$2.2025Dec 18, 2025
Dec 16, 2024$1.8353Dec 16, 2024
Dec 16, 2021$9.9297Dec 16, 2021
Dec 15, 2020$0.5959Dec 15, 2020
Dec 13, 2019$1.5912Dec 13, 2019
Dec 14, 2018$2.9024Dec 14, 2018
Full Dividend History